Integrated specialty Target Holtorf Medical Group’s integrative endocrinology and hormone therapy services for strategic partnerships with pharmaceutical compounding firms, bio-identical hormone suppliers, and IV therapy providers to expand product offerings and improve patient outcomes.

Chronic condition focus Position sales efforts around long-term management of chronic conditions such as thyroid disorders, fibromyalgia, chronic fatigue syndrome, Lyme disease, and hormonal imbalance to align with required ongoing treatment plans and repeat medication/therapy cycles.

Evidence-based care Leverage the group’s commitment to evidence-based protocols to approach academic medical centers and clinical trial networks for joint programs, continuing education, and potential research collaborations that drive referrals.

Mid-market footprint With 11-50 employees and revenue in the mid single-digit millions, pursue scalable B2B opportunities such as outsourced admin/IT support, patient engagement platforms, and revenue-cycle optimization tailored to mid-sized medical groups.

Digital engagement Capitalize on their tech stack and online presence by offering marketing automation, SEO optimization, patient education content, and HIPAA-compliant telehealth tools to enhance patient acquisition and retention.